POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Approval overview POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 018008 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 5GM/100ML;75MG/100ML;450MG/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2019-02-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 018008 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 5GM/100ML;75MG/100ML;450MG/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2019-02-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.